Egyptian Board Hematology - independent subject foundations cheat sheet

Interpret cell counts through production, distribution and survival.

An immunophenotypic enrichment profile is not functional proof of a stem cell.

Read ferritin and vitamin tests in their physiological context.

Use a specified molecular nomenclature, assay and classification framework.

Use component-specific compatibility and relevant antibody history.

Leukoreduction and irradiation address different risks.

Assess competing transfusion-reaction mechanisms rather than rely on one biomarker.

A poor platelet increment is not automatically proof of immune refractoriness.

Distinguish the anemia pattern from its underlying cause.

Iron deficiency, inflammatory restriction and globin disorders can overlap.

Interpret DAT and hemolysis markers through the actual clinical evidence.

Do not use indiscriminate fluids or a universal transfusion rule for sickle-cell pain.

Normal screening tests do not exclude every bleeding disorder.

Interpret mixing, activity and inhibitor tests with timing and interference.

Distinguish TTP, complement disease, consumption and HIT mechanisms.

Anticoagulant choice, interruption and reversal require different patient-specific reasoning.

Integrate morphology, phenotype and molecular evidence instead of classifying from a count alone.

Treat suspected APL and other urgent complications through the appropriate coordinated pathway.

Distinguish a diagnosis from an indication to begin treatment.

Keep transplant type, cellular target and characteristic toxicities separate.